| b7-h4-targeted antibody-drug conjugates, and methods of use thereof |
2023-7-31 |
2023-8-09 |
|
| Peptide-containing linkers for antibody-drug conjugates |
2023-2-13 |
2023-4-25 |
|
| Antibody drug conjugates comprising sting agonists |
2022-12-27 |
2023-5-19 |
|
| Monoclonal antibodies against her2 epitope and methods of use thereof |
2022-10-26 |
2023-8-24 |
|
| Napi2b-targeted polymer antibody-drug conjugate for the treatment of ovarian … |
2022-9-09 |
2023-3-16 |
|
| Protein-polymer-drug conjugates |
2022-7-14 |
2023-6-15 |
|
| NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF |
2022-6-28 |
2022-10-20 |
|
| Site specific antibody-drug conjugates with peptide-containing linkers |
2022-6-27 |
2022-8-01 |
|
| Combination therapy of carboplatin and napi2b-targeted polymer antibody-drug … |
2022-5-03 |
2022-11-10 |
|
| Bis-[n-((5-carbamoyl)-1h-benzo[d]imidazol-2-yl)-pyrazol-5-carboxamide] … |
2022-1-30 |
2022-3-01 |
|
| B7-H4 DIRECTED ANTIBODY AND DRUG CONJUGATES, AND METHODS OF USE THEREOF |
2022-1-04 |
2023-4-12 |
|
| Cysteine engineered antibody-drug conjugates with peptide-containing linkers |
2021-4-19 |
2021-6-30 |
|
| ANTIBODY-DRUG CONJUGATES COMPRISING STING AGONISTS |
2021-4-05 |
2022-7-06 |
|
| Antibody drug conjugates comprising sting agonists |
2021-4-02 |
2022-10-28 |
|
| Napi2b-targeted antibody-drug conjugates and methods of use thereof |
2021-1-20 |
2021-9-30 |
|
| SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING LINKERS |
2021-1-08 |
2022-9-07 |
|
| Methods and nucleic acid molecules for cell-free and vector-free in vitro RNA … |
2021-1-05 |
2022-7-08 |
|
| Methods and nucleic acid molecules for cell-free and vector-free in vitro RNA … |
2021-1-05 |
2022-7-08 |
|
| Cell-free and vector-free in vitro RNA transcription methods and nucleic acid … |
2021-1-05 |
2022-7-08 |
|
| Dimeric compounds as sting agonists |
2020-12-04 |
2023-3-09 |
|
| Protein-Polymer-Drug Conjugate |
2020-10-28 |
2021-3-04 |
|
| STING AGONIST COMPOUNDS, AND METHODS OF USE |
2020-7-31 |
2021-12-29 |
|
| Compositions and methods for predicting response to napi2b-targeted therapy |
2020-3-12 |
2020-4-30 |
|
| Protein-polymer-drug conjugates |
2020-1-23 |
2021-4-15 |
|
| Pyrrolobenzodiazepine antibody conjugates |
2018-12-21 |
2020-10-28 |
|
| Pyrrolobenzodiazepine antibody conjugates |
2018-11-27 |
2020-10-07 |
|
| Pyrrolobenzodiazepines and conjugates thereof |
2018-11-06 |
2020-5-26 |
2020-5-26 |
| Methods of producing drug-loaded polymer scaffolds and protein-polymer-drug … |
2018-6-22 |
2020-6-19 |
|
| Combination therapies of her2-targeted antibody-drug conjugates |
2018-2-27 |
2018-9-07 |
|
| Peptide-containing linkers for antibody-drug conjugates |
2017-11-22 |
2022-11-25 |
|
| Protein-polymer-drug conjugates |
2017-11-16 |
2018-5-24 |
|
| Tubulysin compounds and conjugates thereof |
2017-9-15 |
2018-8-30 |
|
| Pyrrolobenzodiazepines and conjugates thereof |
2017-6-22 |
2022-11-02 |
2022-11-02 |
| ANTIBODY-DRUG CONJUGATES ADDRESSED TO NaPi2b AND ITS METHODS |
2017-3-15 |
2018-11-14 |
|
| Terminally modified polymers and conjugates thereof |
2016-9-08 |
2017-5-04 |
|
| Protein-polymer-drug conjugates -- |
2016-3-18 |
2016-8-19 |
|
| Monoclonal antibodies against her2 epitope and methods of use thereof |
2015-6-18 |
2022-3-15 |
|
| MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE |
2015-6-18 |
2017-4-20 |
|
| MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITHOPE AND ITS METHODS OF USE |
2015-6-18 |
2016-11-16 |
|
| Protein-polymer-drug conjugates and methods of using same |
2015-6-18 |
2015-12-24 |
|
| Hydroxy-polmer-drug-protein conjugates |
2013-12-12 |
2014-6-19 |
|
| Auristatin compounds and conjugates thereof |
2013-12-10 |
2015-11-05 |
|
| Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer … |
2013-6-18 |
2014-1-02 |
|
| Biocompatible biodegradable fumagillin analog conjugates |
2013-2-15 |
2013-6-20 |
|
| Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and … |
2013-1-07 |
2013-5-02 |
|
| PHARMACEUTICAL FORMULATIONS FOR CONJUGATES OF FUMAGILINE AND PHF DERIVATIVES |
2012-12-26 |
2014-9-03 |
|
| Pharmaceutical formulations for fumagillin derivative-phf conjugates |
2012-12-21 |
2014-10-29 |
|
| Protein-polymer-drug conjugates |
2012-6-11 |
2013-12-12 |
|
| Polyal drug conjugates comprising variable rate-releasing linkers |
2011-11-13 |
2012-1-31 |
|
| Modified polymers for delivery of polynucleotides, method of manufacture, and … |
2011-3-28 |
2011-9-29 |
|
| Conjugates Comprising a Biodegradable Polymer and Uses Therefor |
2010-8-27 |
2011-2-24 |
|